BMC Medical Showcases Innovations for Enhanced Breathing at ERS 2025

On October 2, 2025, BMC Medical, a leading global provider of sleep and respiratory solutions, successfully presented its latest innovations during the European Respiratory Society (ERS) international congress in Amsterdam. The company put a strong emphasis on improving patient care by showcasing a comprehensive range of diagnostic and therapeutic solutions, alongside an engaging Skills Lab focused on the future of CPAP monitoring.

Rethinking CPAP Success: A Workshop Spotlight

During a BMC-sponsored Skills Lab titled The Future of CPAP Monitoring - What Needs to Change Today?, leading experts highlighted the necessity for a shift away from traditional 4-hour/night monitoring metrics. Professor Jean-Louis Pépin from France underscored the importance of developing outcome-oriented monitoring, which aligns the therapy with measurable clinical benefits. Similarly, Dr. Renata L. Riha from the UK stressed the significance of integrating multimodal follow-up data, such as oxygenation load and cardiovascular outcomes, into personalized patient care. This session attracted nearly full attendance and sparked widespread discussions within the ERS community, emphasizing the urgent need to redefine CPAP success for contemporary healthcare.

Comprehensive Solutions: From Diagnosis to Therapy

At the BMC booth, innovations from across the realm of sleep medicine were showcased, including the G3 A20 Auto CPAP featuring an advanced algorithm, the portable M1 Mini APAP, and the newly launched 6S masks. The company also introduced its latest diagnostic solutions, including the PolyWatch YH-600 series and the new YH-S900B and YH-S900C Home Sleep Test devices. These offerings reinforce BMC's commitment to holistic, patient-centered airway care that bridges diagnosis and therapy seamlessly.

Engagement and Community Commitment

The BMC booth attracted over 500 doctors and healthcare professionals, fostering global conversations about innovation, clinical benefits, and practical patient care. Participants also engaged in brand-centric moments by sharing photos with the BMC hand sign, which symbolizes collaboration and a shared mission for better breathing.

A Shared Future for Airway Health

Dr. Abdelkebir Sabil, Global Medical Director at BMC, articulated the significance of ERS 2025 as a milestone to connect with the global respiratory community. He stated, "Our vision is to go beyond usage metrics and provide meaningful outcomes and empathetic care for patients around the world." BMC extends its gratitude to all partners, staff, and attendees who participated in Amsterdam, reinforcing their dedication to building a future focused on better sleep and healthier breathing.

About BMC Medical

Founded in 2001, BMC Medical is dedicated to supporting families worldwide with quality products, professional service, and proactive care in managing chronic respiratory conditions. The company continues to innovate and expand its offerings, aiming for excellence in patient care and overall health management.

BMC Team at ERS 2025